Clinical Trials in San Antonio

Showing 4141-4160 of 14,633 trials

LITMUS Imaging Study

NCT05479721

The LITMUS Imaging Study is a prospectively recruited, observational study of patients with histologically characterised non-alcoholic fatty liver disease (NAFLD). It aims to evaluate the diagnostic performance of imaging biomarkers (ultrasound elastography and magnetic resonance biomarkers) against NAFLD histological scores in a cross-sectional analysis and the natural history of NAFLD in a longitudinal study.

NAFLDNASHNASH - Nonalcoholic Steatohepatitis+2 more

University of Oxford450 participantsStarted Sep 2019

San Antonio, Texas, United States • Helsinki, Finland • Angers, France +15 more locations

Active Not RecruitingPhase 3< 1 mile

Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

NCT05257408

The primary objectives of this study are to evaluate progression-free survival (PFS) by blinded independent central review (BICR) and overall survival (OS) (evaluated independently, as dual primary endpoints) in patients treated with intermittent regimen of Relacorilant in combination with nab-paclitaxel compared with patients treated with nab-paclitaxel monotherapy.

Ovarian NeoplasmFallopian Tube NeoplasmsPeritoneal Neoplasms

Corcept Therapeutics381 participantsStarted Jun 2022

Phoenix, Arizona, United States • Tucson, Arizona, United States • Irvine, California, United States +114 more locations

LITMUS Imaging Study

Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

Find Trials by Condition in San Antonio

Ketamine & Crisis Response Plan for Suicidal Ideation in the ED

The SHUNT-V Study for Varices

Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors

R3 Delta Ceramic Acetabular System PAS U.S.

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis

Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation

MRI to Characterize and Predict CF Liver Disease in PUSH Cohort

Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis

The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

Tritanium® Primary Acetabular Shell Study

A Study to Assess the Safety, Tolerability, and Efficacy of Namilumab in Participants With Active Cardiac Sarcoidosis

An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia